Literature DB >> 32232774

Kidney health for everyone everywhere: from prevention to detection and equitable access to care.

Philip Kam-Tao Li1, Guillermo Garcia-Garcia2, Siu-Fai Lui3, Sharon Andreoli4, Winston Wing-Shing Fung5, Anne Hradsky6, Latha Kumaraswami7, Vassilios Liakopoulos8, Ziyoda Rakhimova6, Gamal Saadi9, Luisa Strani6, Ifeoma Ulasi10, Kamyar Kalantar-Zadeh11.   

Abstract

The global burden of chronic kidney disease (CKD) is rapidly increasing with a projection of becoming the 5th most common cause of years of life lost globally by 2040. Aggravatingly, CKD is a major cause of catastrophic health expenditure. The costs of dialysis and transplantation consume up to 3% of the annual healthcare budget in high-income countries. Crucially, however, the onset and progression of CKD is often preventable. In 2020, the World Kidney Day campaign highlights the importance of preventive interventions-be it primary, secondary or tertiary. This complementing article focuses on outlining and analyzing measures that can be implemented in every country to promote and advance CKD prevention. Primary prevention of kidney disease should focus on the modification of risk factors and addressing structural abnormalities of the kidney and urinary tracts, as well as exposure to environmental risk factors and nephrotoxins. In persons with pre-existing kidney disease, secondary prevention, including blood pressure optimization and glycemic control, should be the main goal of education and clinical interventions. In patients with advanced CKD, management of co-morbidities such as uremia and cardiovascular disease is a highly recommended preventative intervention to avoid or delay dialysis or kidney transplantation. Political efforts are needed to proliferate the preventive approach. While national policies and strategies for non-communicable diseases might be present in a country, specific policies directed toward education and awareness about CKD screening, management and treatment are often lacking. Hence, there is an urgent need to increase the awareness of the importance of preventive measures throughout populations, professionals and policy makers.

Entities:  

Keywords:  Awareness; Detection; Kidney diseases; Prevention

Mesh:

Year:  2020        PMID: 32232774     DOI: 10.1007/s40620-020-00728-x

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  48 in total

1.  Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.

Authors:  Héctor R Martínez-Ramírez; Basilio Jalomo-Martínez; Laura Cortés-Sanabria; Enrique Rojas-Campos; Graciela Barragán; Gilberto Alfaro; Alfonso M Cueto-Manzano
Journal:  Am J Kidney Dis       Date:  2006-01       Impact factor: 8.860

2.  Effective CKD care in European countries: challenges and opportunities for health policy.

Authors:  Aminu K Bello; Adeera Levin; Braden J Manns; John Feehally; Tilman Drueke; Labib Faruque; Brenda R Hemmelgarn; Charles Kernahan; Johannes Mann; Scott Klarenbach; Giuseppe Remuzzi; Marcello Tonelli
Journal:  Am J Kidney Dis       Date:  2014-11-05       Impact factor: 8.860

Review 3.  Reducing major risk factors for chronic kidney disease.

Authors:  Valerie A Luyckx; Katherine R Tuttle; Guillermo Garcia-Garcia; Mohammed Benghanem Gharbi; Hiddo J L Heerspink; David W Johnson; Zhi-Hong Liu; Ziad A Massy; Orson Moe; Robert G Nelson; Laura Sola; David C Wheeler; Sarah L White
Journal:  Kidney Int Suppl (2011)       Date:  2017-09-20

4.  Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.

Authors:  Dun-Sol Go; Seon-Ha Kim; Jongha Park; Dong-Ryeol Ryu; Hyeon-Jeong Lee; Min-Woo Jo
Journal:  Nephrology (Carlton)       Date:  2019-01       Impact factor: 2.506

Review 5.  Nutritional Management of Chronic Kidney Disease.

Authors:  Kamyar Kalantar-Zadeh; Denis Fouque
Journal:  N Engl J Med       Date:  2017-11-02       Impact factor: 91.245

Review 6.  Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline.

Authors:  Howard A Fink; Areef Ishani; Brent C Taylor; Nancy L Greer; Roderick MacDonald; Dominic Rossini; Sameea Sadiq; Srilakshmi Lankireddy; Robert L Kane; Timothy J Wilt
Journal:  Ann Intern Med       Date:  2012-04-17       Impact factor: 25.391

7.  The primary care perspective on routine urine dipstick screening to identify patients with albuminuria.

Authors:  Lipika Samal; Jeffrey A Linder
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-23       Impact factor: 8.237

8.  Relatives in silent kidney disease screening (RISKS) study: A Chinese cohort study.

Authors:  Philip Kam-Tao Li; Jack Kit-Chung Ng; Yuk Lun Cheng; Tze Hoi Kwan; Chi Bon Leung; Miu Fong Lau; Koon Shing Choi; Samuel Ka-Shun Fung; Yiu Wing Ho; Siu Ka Mak; Sydney Chi-Wai Tang; Kin Shing Wong; David Yong; Sing Leung Lui
Journal:  Nephrology (Carlton)       Date:  2017-12       Impact factor: 2.506

Review 9.  Chronic kidney disease in low-income to middle-income countries: the case for increased screening.

Authors:  Cindy George; Amelie Mogueo; Ikechi Okpechi; Justin B Echouffo-Tcheugui; Andre Pascal Kengne
Journal:  BMJ Glob Health       Date:  2017-05-29

10.  Rationale and population-based prospective cohort protocol for the disadvantaged populations at risk of decline in eGFR (CO-DEGREE).

Authors:  Ben Caplin; Neil Pearce; Marvin Gonzalez-Quiroz; Dorothea Nitsch; Sophie Hamilton; Cristina O'Callaghan Gordo; Rajiv Saran; Jason Glaser; Ricardo Correa-Rotter; Kristina Jakobsson; Ajay Singh; Nalika Gunawardena; Adeera Levin; Giuseppe Remuzzi
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

View more
  1 in total

1.  1,25-dihydroxyvitamin D as Predictor of Renal Worsening Function in Chronic Kidney Disease. Results From the PASCaL-1,25D Study.

Authors:  Andrea Galassi; Eliana Maria Fasulo; Paola Ciceri; Roberta Casazza; Fabrizio Bonelli; Claudia Zierold; Mariella Calleri; Frank A Blocki; Maria Assunta Palmieri; Claudio Mastronardo; Mario G Cozzolino
Journal:  Front Med (Lausanne)       Date:  2022-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.